Review



recombinant mouse alk1fc  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91

    Structured Review

    R&D Systems recombinant mouse alk1fc
    FSS stimulation activates multiple distinct TGFβ family type I receptors in OCY454 cells. A, qRT‐PCR analysis of TGFβ target gene Serpine1 after 60‐minute treatment with vehicle or SB‐431542 followed by 120‐minute treatment with TGFβ or FSS stimulation as indicated (n = 4 biological replicates). All values normalized to control cells. * P < .05 compared to unstimulated cells and # P < .05 compared to SB‐treated controls; † P < .05 compared to corresponding treatment group without SB‐431542, ‡ P < .05 compared to FSS‐stimulated cells. B, C, Representative western analysis of Smad phosphorylation in control cells and cells pretreated (60 minutes) with vehicle or an inhibitor of a subset of TGFβ type I receptors (SB‐431542, ALK4/5/7 inhibitor; LDN‐193189, ALK1/2/3/6 inhibitor; LDN‐214117, ALK1/2 inhibitor, as shown in B), followed by treatment (30 minutes) with TGFβ or FSS (C) (n = 3 biological replicates). D, Representative western analysis of cells pretreated (60 minutes) with <t>ALK1Fc</t> followed by treatment (30 minutes) with TGFβ, BMP4, or FSS (n = 2 biological replicates, non‐flow conditions were collected from cells grown in well plates)
    Recombinant Mouse Alk1fc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse alk1fc/product/R&D Systems
    Average 91 stars, based on 14 article reviews
    recombinant mouse alk1fc - by Bioz Stars, 2026-03
    91/100 stars

    Images

    1) Product Images from "Fluid shear stress generates a unique signaling response by activating multiple TGFβ family type I receptors in osteocytes"

    Article Title: Fluid shear stress generates a unique signaling response by activating multiple TGFβ family type I receptors in osteocytes

    Journal: The FASEB Journal

    doi: 10.1096/fj.202001998R

    FSS stimulation activates multiple distinct TGFβ family type I receptors in OCY454 cells. A, qRT‐PCR analysis of TGFβ target gene Serpine1 after 60‐minute treatment with vehicle or SB‐431542 followed by 120‐minute treatment with TGFβ or FSS stimulation as indicated (n = 4 biological replicates). All values normalized to control cells. * P < .05 compared to unstimulated cells and # P < .05 compared to SB‐treated controls; † P < .05 compared to corresponding treatment group without SB‐431542, ‡ P < .05 compared to FSS‐stimulated cells. B, C, Representative western analysis of Smad phosphorylation in control cells and cells pretreated (60 minutes) with vehicle or an inhibitor of a subset of TGFβ type I receptors (SB‐431542, ALK4/5/7 inhibitor; LDN‐193189, ALK1/2/3/6 inhibitor; LDN‐214117, ALK1/2 inhibitor, as shown in B), followed by treatment (30 minutes) with TGFβ or FSS (C) (n = 3 biological replicates). D, Representative western analysis of cells pretreated (60 minutes) with ALK1Fc followed by treatment (30 minutes) with TGFβ, BMP4, or FSS (n = 2 biological replicates, non‐flow conditions were collected from cells grown in well plates)
    Figure Legend Snippet: FSS stimulation activates multiple distinct TGFβ family type I receptors in OCY454 cells. A, qRT‐PCR analysis of TGFβ target gene Serpine1 after 60‐minute treatment with vehicle or SB‐431542 followed by 120‐minute treatment with TGFβ or FSS stimulation as indicated (n = 4 biological replicates). All values normalized to control cells. * P < .05 compared to unstimulated cells and # P < .05 compared to SB‐treated controls; † P < .05 compared to corresponding treatment group without SB‐431542, ‡ P < .05 compared to FSS‐stimulated cells. B, C, Representative western analysis of Smad phosphorylation in control cells and cells pretreated (60 minutes) with vehicle or an inhibitor of a subset of TGFβ type I receptors (SB‐431542, ALK4/5/7 inhibitor; LDN‐193189, ALK1/2/3/6 inhibitor; LDN‐214117, ALK1/2 inhibitor, as shown in B), followed by treatment (30 minutes) with TGFβ or FSS (C) (n = 3 biological replicates). D, Representative western analysis of cells pretreated (60 minutes) with ALK1Fc followed by treatment (30 minutes) with TGFβ, BMP4, or FSS (n = 2 biological replicates, non‐flow conditions were collected from cells grown in well plates)

    Techniques Used: Quantitative RT-PCR, Western Blot



    Similar Products

    91
    R&D Systems recombinant mouse alk1fc
    FSS stimulation activates multiple distinct TGFβ family type I receptors in OCY454 cells. A, qRT‐PCR analysis of TGFβ target gene Serpine1 after 60‐minute treatment with vehicle or SB‐431542 followed by 120‐minute treatment with TGFβ or FSS stimulation as indicated (n = 4 biological replicates). All values normalized to control cells. * P < .05 compared to unstimulated cells and # P < .05 compared to SB‐treated controls; † P < .05 compared to corresponding treatment group without SB‐431542, ‡ P < .05 compared to FSS‐stimulated cells. B, C, Representative western analysis of Smad phosphorylation in control cells and cells pretreated (60 minutes) with vehicle or an inhibitor of a subset of TGFβ type I receptors (SB‐431542, ALK4/5/7 inhibitor; LDN‐193189, ALK1/2/3/6 inhibitor; LDN‐214117, ALK1/2 inhibitor, as shown in B), followed by treatment (30 minutes) with TGFβ or FSS (C) (n = 3 biological replicates). D, Representative western analysis of cells pretreated (60 minutes) with <t>ALK1Fc</t> followed by treatment (30 minutes) with TGFβ, BMP4, or FSS (n = 2 biological replicates, non‐flow conditions were collected from cells grown in well plates)
    Recombinant Mouse Alk1fc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant mouse alk1fc/product/R&D Systems
    Average 91 stars, based on 1 article reviews
    recombinant mouse alk1fc - by Bioz Stars, 2026-03
    91/100 stars
      Buy from Supplier

    Image Search Results


    FSS stimulation activates multiple distinct TGFβ family type I receptors in OCY454 cells. A, qRT‐PCR analysis of TGFβ target gene Serpine1 after 60‐minute treatment with vehicle or SB‐431542 followed by 120‐minute treatment with TGFβ or FSS stimulation as indicated (n = 4 biological replicates). All values normalized to control cells. * P < .05 compared to unstimulated cells and # P < .05 compared to SB‐treated controls; † P < .05 compared to corresponding treatment group without SB‐431542, ‡ P < .05 compared to FSS‐stimulated cells. B, C, Representative western analysis of Smad phosphorylation in control cells and cells pretreated (60 minutes) with vehicle or an inhibitor of a subset of TGFβ type I receptors (SB‐431542, ALK4/5/7 inhibitor; LDN‐193189, ALK1/2/3/6 inhibitor; LDN‐214117, ALK1/2 inhibitor, as shown in B), followed by treatment (30 minutes) with TGFβ or FSS (C) (n = 3 biological replicates). D, Representative western analysis of cells pretreated (60 minutes) with ALK1Fc followed by treatment (30 minutes) with TGFβ, BMP4, or FSS (n = 2 biological replicates, non‐flow conditions were collected from cells grown in well plates)

    Journal: The FASEB Journal

    Article Title: Fluid shear stress generates a unique signaling response by activating multiple TGFβ family type I receptors in osteocytes

    doi: 10.1096/fj.202001998R

    Figure Lengend Snippet: FSS stimulation activates multiple distinct TGFβ family type I receptors in OCY454 cells. A, qRT‐PCR analysis of TGFβ target gene Serpine1 after 60‐minute treatment with vehicle or SB‐431542 followed by 120‐minute treatment with TGFβ or FSS stimulation as indicated (n = 4 biological replicates). All values normalized to control cells. * P < .05 compared to unstimulated cells and # P < .05 compared to SB‐treated controls; † P < .05 compared to corresponding treatment group without SB‐431542, ‡ P < .05 compared to FSS‐stimulated cells. B, C, Representative western analysis of Smad phosphorylation in control cells and cells pretreated (60 minutes) with vehicle or an inhibitor of a subset of TGFβ type I receptors (SB‐431542, ALK4/5/7 inhibitor; LDN‐193189, ALK1/2/3/6 inhibitor; LDN‐214117, ALK1/2 inhibitor, as shown in B), followed by treatment (30 minutes) with TGFβ or FSS (C) (n = 3 biological replicates). D, Representative western analysis of cells pretreated (60 minutes) with ALK1Fc followed by treatment (30 minutes) with TGFβ, BMP4, or FSS (n = 2 biological replicates, non‐flow conditions were collected from cells grown in well plates)

    Article Snippet: Except where noted in the figures, cells were treated as indicated with TGFβ1 (5 ng/mL), BMP4 (50 ng/mL) (both from Peprotech); 1d11 (1.25 µg/mL, Clone 1d11.16.8, BioXCell); Noggin (100 ng/mL, SRP3227, Sigma Aldrich); SB‐431542 (10 µM), LDN‐193189 (1 µM), LDN‐214117 (1 µM), SC‐79 (10 µM) (all from Selleckchem); recombinant mouse ALK1Fc (100 ng/mL, R&D Systems); and LY294002 (50 µM, Calbiochem).

    Techniques: Quantitative RT-PCR, Western Blot